Skip to content
Clinical Trials – home
Therapeutic area

General disorders and administration site conditions – page 10

  • 140 clinical trials
  • 57 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ticagrelor
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Centre Hospitalier Universitaire De Nantes
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ropivacaine Hydrochloride
  • Sponsor:Pirkanmaan hyvinvointialue

Pain

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ibuprofen
  • Sponsor:Farmalider S.A.

Chronic fatigue syndrome+1

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Pregabalin
  • Sponsor:Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Critical illness

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tetracosactide
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Omaveloxolone
  • Sponsor:Reata Pharmaceuticals Inc.

Still's disease

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elinzanetant
  • Sponsor:Bayer AG
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.